BPH - Benign Prostatic Enlargement - Results from #340

Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study. July 30, 2023

Ejaculation physiology and dysfunction after BPH surgery: the role of the new MISTs. July 30, 2023

Trends of Benign Prostatic Hyperplasia (BPH) procedures in Ambulatory Surgery Settings. July 30, 2023

Holmium laser with MOSES technology (MoLEP) vs Thulium fiber laser enucleation of the prostate (ThuFLEP) in a real-world setting. Mid-term outcomes from a multicenter propensity score analysis. July 30, 2023

The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. July 23, 2023

Symptomatic Benign Prostatic Hyperplasia Is Not Associated With a Higher Risk of Periprosthetic Joint Infections and Periprosthetic Joint Infection-related Revisions After Primary THA. July 23, 2023

The causal effect of metabolic syndrome and its components on benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study. July 23, 2023

Urotronic Announces Completion of the World’s First Optilume® BPH Catheter System Commercial Procedure in Toronto July 19, 2023

Treatment patterns in men prescribed benign prostatic obstruction or overactive bladder medications in Canada: a retrospective population-based study. July 17, 2023

Evolution of non-perfused volume after transurethral ultrasound ablation of prostate: A retrospective 12-month analysis. July 17, 2023

Diagnostic work-up of benign prostatic hyperplasia : The German S2e-guideline 2023 part 1. July 16, 2023

Overview of current pharmacotherapeutic options in benign prostatic hyperplasia. July 16, 2023

Urotronic Announces FDA Approval of Optilume® BPH Catheter System, Pioneering the Next Generation of Minimally Invasive Solutions for Enlarged Prostate Symptom Relief July 11, 2023

Comparison Between Thulium Fiber Laser and High-power Holmium Laser for Anatomic Endoscopic Enucleation of the Prostate: A Propensity Score-matched Analysis from the REAP Registry. July 9, 2023

Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. July 9, 2023

Investigating trends in interest for benign prostatic hyperplasia surgery options using Google Trends. July 9, 2023

Network meta-analysis of the treatment safety and efficacy of different energy systems in prostate vaporization. July 3, 2023

US patterns of care for urodynamic evaluation for BPH. July 3, 2023

Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS. July 2, 2023

Outcomes of holmium laser enucleation of the prostate (HoLEP) for very large-sized benign prostatic hyperplasia (over 150 mL): open simple prostatectomy is dead. July 2, 2023

Page 18 of 143